Evaluation of cardiac parameters and other safety outcomes of brolucizumab treatment in patients with neovascular age‐related macular degeneration

This was a prospective, single‐dose, single‐arm, open‐label, non‐randomized, multicenter clinical study to determine cardiovascular safety after a single brolucizumab 6 mg intravitreal injection in neovascular age‐related macular degeneration patients (N = 14). Electrocardiogram (ECG) data were coll...

Descripción completa

Detalles Bibliográficos
Autores principales: Zakaria, Nadia, Guerard, Nicolas, Emanuelli, Andres, Dugel, Pravin, Watts, Jen, Liew, Melissa, Gekkieva, Margarita, Hinder, Markus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931501/
https://www.ncbi.nlm.nih.gov/pubmed/35301822
http://dx.doi.org/10.1002/prp2.897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931501/
https://www.ncbi.nlm.nih.gov/pubmed/35301822
http://dx.doi.org/10.1002/prp2.897

Ejemplares similares